Document Detail

Overcoming obstacles in Parkinson's disease.
MedLine Citation:
PMID:  23115047     Owner:  NLM     Status:  Publisher    
Improved symptomatic and disease-modifying treatments are needed for Parkinson's disease (PD). Although significant advances have been made in the understanding of PD etiology, the translation of these discoveries into novel transformative therapies has been limited as a result of systemic challenges in PD drug development. Preclinical testing lacks clear standards and prioritization criteria for advancing therapies to the clinic. Clinical testing is marked by expensive, long, and uninformative studies. In parallel to these scientific challenges, funding of late-stage drug development has become increasingly scarce and risk averse. In this context, novel models of collaboration and funding are opening up new avenues for pursuing treatments. This review will discuss the most critical challenges in PD drug development and the innovative approaches being developed to overcome these hurdles. © 2012 Movement Disorder Society.
Todd B Sherer; Sohini Chowdhury; Katherine Peabody; Deborah W Brooks
Related Documents :
24111907 - An update on the chemistry and medicinal chemistry of novel antimycobacterial compounds.
24355247 - Natural product based leads to fight against leishmaniasis.
20605997 - Acceptable risks and burdens for children in research without direct benefit: a systema...
10106657 - Prescribing for unlabeled conditions: patient benefit or therapeutic roulette?
1952837 - Treatment of murine cryptococcal meningitis with an sch 39304-amphotericin b combination.
7962217 - National cancer institute drug information system 3d database.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-31
Journal Detail:
Title:  Movement disorders : official journal of the Movement Disorder Society     Volume:  -     ISSN:  1531-8257     ISO Abbreviation:  Mov. Disord.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-11-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8610688     Medline TA:  Mov Disord     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Movement Disorder Society.
The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenici...
Next Document:  Adult Hyperglycemic Crisis: A Review and Perspective.